These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 25096430)

  • 1. Duchenne muscular dystrophy.
    Annexstad EJ; Lund-Petersen I; Rasmussen M
    Tidsskr Nor Laegeforen; 2014 Aug; 134(14):1361-4. PubMed ID: 25096430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.
    McDonald CM; Henricson EK; Abresch RT; Duong T; Joyce NC; Hu F; Clemens PR; Hoffman EP; Cnaan A; Gordish-Dressman H;
    Lancet; 2018 Feb; 391(10119):451-461. PubMed ID: 29174484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urological manifestations of Duchenne muscular dystrophy.
    Askeland EJ; Arlen AM; Erickson BA; Mathews KD; Cooper CS
    J Urol; 2013 Oct; 190(4 Suppl):1523-8. PubMed ID: 23357214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid therapy for duchenne muscular dystrophy: improvement of psychomotor function.
    Sato Y; Yamauchi A; Urano M; Kondo E; Saito K
    Pediatr Neurol; 2014 Jan; 50(1):31-7. PubMed ID: 24138948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the management of Duchenne muscular dystrophy.
    Manzur AY; Kinali M; Muntoni F
    Arch Dis Child; 2008 Nov; 93(11):986-90. PubMed ID: 18667451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.
    Spurney CF
    Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Duchenne muscular dystrophy: current aspects and perspectives on treatment].
    López-Hernández LB; Vázquez-Cárdenas NA; Luna-Padrón E
    Rev Neurol; 2009 Oct 1-15; 49(7):369-75. PubMed ID: 19774532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform.
    Lim BC; Lee S; Shin JY; Kim JI; Hwang H; Kim KJ; Hwang YS; Seo JS; Chae JH
    J Med Genet; 2011 Nov; 48(11):731-6. PubMed ID: 21969337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
    Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
    Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community.
    Verma S; Anziska Y; Cracco J
    Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy.
    American Academy of Pediatrics Section on Cardiology and Cardiac Surgery
    Pediatrics; 2005 Dec; 116(6):1569-73. PubMed ID: 16322188
    [TBL]